Announces - International Biopharmaceutical Industry

news

PharmaKrysto announces licensing agreement with Rutgers University for new treatment for people with cystinuria

PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today that it has completed an exclusive global licensing deal with Rutgers University,...

13 July 2018 news agreement | Announces

Continue Reading →

news

Alpha Biopharma announces series A financing

AZD3759, AlphaBio's lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor r...

22 June 2018 news Alpha | Announces

Continue Reading →

news

Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors

Orchard Therapeutics, a leading commercial stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies,...

8 June 2018 news Announces | appointments

Continue Reading →

news

Bavarian Nordic Announces Acceptance of Abstracts and Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the acceptance of 4 poster presentations and one podium presentation at the American Society of Clinical O...